CD4 and colitis: Taken together, these results indicate that MHCII expression by IECs attenuates bacterial-driven colitis by preventing exacerbated effector Th1 cell accumulation and the establishment of an unfavourably altered ratio between conventional CD4+ T cells and FoxP3+ Treg cells.